- Home
- FBNC vs NKTR Comparison
FBNC vs NKTR Comparison
Compare FBNC & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$81.69
Company Overview
Basic Information| Metric | FBNC | NKTR |
|---|---|---|
| Founded | 1934 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.1B |
| IPO Year | 1995 | 1996 |
Fundamental Metrics
Financial Performance| Metric | FBNC | NKTR |
|---|---|---|
| Price | $59.07 | $81.69 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 7 |
| Target Price | $62.25 | ★ $146.67 |
| AVG Volume (30 Days) | 157.8K | ★ 1.1M |
| Earning Date | 04-22-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.67% | N/A |
| EPS Growth | ★ 45.65 | N/A |
| EPS | ★ 1.13 | N/A |
| Revenue | $67,623,000.00 | ★ $307,711,000.00 |
| Revenue This Year | $37.82 | N/A |
| Revenue Next Year | $2.30 | N/A |
| P/E Ratio | $22.13 | ★ N/A |
| Revenue Growth | N/A | ★ 86.00 |
| 52 Week Low | $40.01 | $0.61 |
| 52 Week High | $62.64 | $109.00 |
Technical Indicators
Market Signals| Indicator | FBNC | NKTR |
|---|---|---|
| Relative Strength Index (RSI) | 54.47 | 48.04 |
| Support Level | $55.54 | $81.30 |
| Resistance Level | $60.11 | $109.00 |
| Average True Range (ATR) | 1.62 | 4.97 |
| MACD | -0.05 | -1.33 |
| Stochastic Oscillator | 67.48 | 3.61 |
Price Performance
Historical Comparison FBNC
NKTR
About FBNC First Bancorp
First Bancorp is a bank holding company. The company is engaged in providing commercial and consumer banking services, mortgage lending, SBA lending, accounts receivable financing, and investment advisory services.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.